The preparation is a medicine that intervenes in the development of blood platelets. It reduces the number of platelets produced in the bone marrow and in this way reduces the number of platelets circulating in the blood back to normal levels. For this reason, the drug is used to treat patients with essential thrombocythemia
Xagrid 0.5mg,100pcs
€434.60
The medicine contains the active ingredient anagrelide.
